AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019The initial Phase 1 evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next generation HIV maturation inhibitor, as assessed in healthy subjectsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Population pharmacokinetics of VRC01 in infants and adultsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019In silico design of a microarray patch as a multipurpose prevention technologyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Efavirenz pharmacokinetics in HIV/TB coinfected persons initiating ART while receiving high dose rifapentineView Abstract
AbstractViral Hepatitis and Liver DiseaseRSVConference on Liver Disease in Africa (COLDA) 2019Hepatitis Function of Illicit Drugs Users: A cross-sectional study in Yaounde-CameroonView Abstract
AbstractViral Hepatitis and Liver DiseaseRSVConference on Liver Disease in Africa (COLDA) 2019In African livers also, steatosis is a frequent background for cancerView Abstract
AbstractViral Hepatitis and Liver DiseaseRSVConference on Liver Disease in Africa (COLDA) 2019Assessment of Vitamin D levels Among chronic Hepatitis B virus population in Khartoum. SudanView Abstract
AbstractViral Hepatitis and Liver DiseaseRSVConference on Liver Disease in Africa (COLDA) 2019Drug-Induced Acute Liver Failure and Vanishing Bile Duct Syndrome after Levofloxacin Azithromycin combination for the Treatment of PneumoniaView Abstract
AbstractViral Hepatitis and Liver DiseaseRSVConference on Liver Disease in Africa (COLDA) 2019Prevalence of liver function tests abnormality and associated factors among type 2 diabetes mellitus patients: a comparative cross-sectional studyView Abstract
AbstractViral Hepatitis and Liver DiseaseRSVConference on Liver Disease in Africa (COLDA) 2019Investigating current gaps and unmet needs in epidemiology practice in the light of rising nash cases in Malawi.View Abstract
AbstractRSVViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2019Cancer primitif du foie sur hépatopathies virales B et/ou C au CHU Sourô Sanou.View Abstract
AbstractViral Hepatitis and Liver DiseaseRSVConference on Liver Disease in Africa (COLDA) 2019Erythrocyte sedimentation rate in hepatocellular carcinoma: Are we ignoring a potential bio-marker?View Abstract
